AI bet goes awry: Oracle fires 21,000 employees
The global race for dominance in artificial intelligence is turning into one of the most expensive and turbulent…
Pelico Secures Strategic Investment from AE Ventures to Accelerate AI-Powered Manufacturing Orchestration Across Aerospace and Defense
FARNBOROUGH, England, July 23, 2026 /PRNewswire/ — Pelico, the manufacturing orchestration platform powering factory operations for the world’s…
The Wireless Display Kit That Needs No App, No Network, No Pairing
There’s no shortage of ways to get your screen onto a larger display these days, but the experience…
JPMorgan: Dramatic jump in AI ETFs despite rough quarter
Wall Street is banking heavily on exchange-traded funds that give investors artificial intelligence exposure, according to J.P. Morgan…
Generative AI use in Japan doubles to 59% in FY 2025: gov’t white paper
TOKYO – The percentage of people in Japan who had used generative artificial intelligence roughly doubled from the…
New on WhatsApp: Edit PDFs and have messages read aloud in your car
SAN JOSE: WhatsApp will soon allow users to open PDF documents directly in the messenger without having to…
What is China’s Kimi K3 and why is the US so rattled by it?
Hong Kong — Remember DeepSeek? The Chinese artificial intelligence startup that rattled the US tech industry with its model…
Bio-inspired ear probe may enhance early hearing loss diagnosis
Binghamton University Assistant Professor Jian Zhou, PhD ’18, will lead a five-year, $1.84 million project funded by the…
Nokia’s Massive AI Orders Overshadow Soft Guidance — BofA Sees 90% Upside
Bank of America increased its price target on Nokia to $18.50, implying a 90% upside. The firm expects…
Sony’s Monitor & Control App now includes EL Zone
Sony has updated its Monitor & Control app, and it now includes the ability to use EL Zone,…
Google’s ATLAS effort seeks to analyze AI usage
Meta CEO Mark Zuckerberg laid out an optimistic vision for artificial intelligence, arguing the technology should empower billions…
EMERALD-3 Shows Benefit With STRIDE Plus TACE in Hepatocellular Carcinoma
Results of the phase III EMERALD-3 trial showed that combining transarterial chemoembolization (TACE) with the immunotherapy-based STRIDE…